REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) › Cash & EquivalentsREVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2018: $02019: $1932020: $8.76M2021: $29.69M2022: $18.52M2023: $23.37M2024: $13.48M2025: $14.44M$14.44M2018Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$14.44M+7.1%2024$13.48M-42.3%2023$23.37M+26.2%2022$18.52M-37.6%2021$29.69M+238.9%2020$8.76M+4538999.5%2019$193—2018$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share